IC-OS International Cardio-Oncology Society-Nursing
The International Cardio-Oncology Society-Nursing workgroup exists to advance the cardiovascular care of cancer patients and survivors by promoting the training and education of Cardio-Oncology nurses around the world.
On behalf of the International Cardio-Oncology Society (IC-OS) Nursing Research Committee, we are conducting a survey to assess the learning needs of nurses interested in Cardio-Oncology practice. As a RN providing care to Cardio-Oncology patients, you have been identified as an expert to identify the knowledge and skills that a nurse needs to be competent in Cardio-Oncology nursing. The insight obtained from the survey will help the IC-OS Nursing Researchers in designing an educational curriculum to develop a Cardio-Oncology Nursing Education (CONE) Program specifically tailored to the needs of Cardio-Oncology nursing. Participation is voluntary.
The link below will take you to the Participant Information Flier that describes the survey. The survey consists of answering multiple choice questions and will take approximately 5 minutes to complete. Following the survey, you may choose to be redirected to the IC-OS mailing list website (optional).
Anecita Fadol PhD, FNP-BC, FAANP, FAAN, FHKAN, Associate Professor with a dual appointment in the Department of Nursing and Department of Cardiology at the University of Texas MD Anderson Cancer Center, is the Principal Investigator of the study. If you have any questions or concerns about this email or the project, please contact Anecita Fadol at email@example.com or Valerie Shelton, Clinical Studies Coordinator, at firstname.lastname@example.org.
You may open the survey in your web browser by clicking the link below:
We sincerely appreciate your valuable time. Thank you so much for your cooperation.
There are no upcoming events at this time.
Half Day Nursing Practice Workshop
OCTOBER 5, 2021
- Topic 1: Foundational Building Blocks for a Successful Cardio-Oncology Program
- Topic 2: “Strength Matters;: Importance of cardiac surveillance for Anthracycline-based
chemotherapy regimens with subsequent treatment with Her2 Targeted Therapy
- Topic 3: Safe for Oral Consumption; but are they really? Importance of awareness of
some oral therapies and immunotherapies potential cardiac side effects
- Topic 4 : Congratulations you rang the bell! What’s next? Survivorship support and programs.